Taking oxycodone at the same time as certain selective serotonin reuptake inhibitors (SSRIs), a commonly prescribed class of antidepressant, can increase the risk of opioid overdose, according to a study my colleagues and ...
Jul 29, 2022
0
3
Targeting a parasite's DNA could be a more effective way to combat malaria, new research from the University of Sheffield has revealed.
Jul 25, 2022
0
17
Scientists have developed artificial intelligence software that can create proteins that may be useful as vaccines, cancer treatments, or even tools for pulling carbon pollution out of the air.
Jul 21, 2022
0
1441
A team of University of Kentucky researchers led by College of Engineering Professor Dibakar Bhattacharyya, Ph.D., and his Ph.D. student, Rollie Mills, have developed a medical face mask membrane that can capture and deactivate ...
Jul 21, 2022
0
150
In children in the US and UK, a sudden increase in the number of cases of severe acute hepatitis of unknown causes (SAHUC) and pediatric acute liver failure was reported between October 2021 and May 2022. As of June 22, 2022, ...
Jul 19, 2022
0
16
For a drug to be effective and not harmful it needs to be administered at the right dosage. Certain enzymes in the body eliminate drugs, and the activity of these enzymes vary between individuals. Researchers at the Max Planck ...
Jul 8, 2022
0
86
Acute cholangitis is a potentially life-threatening bacterial infection that often is associated with gallstones. Symptoms include fever, jaundice, right upper quadrant pain, and elevated liver enzymes.
Jul 1, 2022
0
4
New research shows a group of enzymes may have a critical role in the process of how immune cells are activated and then migrate to certain sites in the body—findings that could improve our understanding of inflammation ...
Jun 20, 2022
0
14
Patients with chronic liver disease may suffer hepatic complications as a result of severe COVID-19. A study conducted by a research team led by Lukas Hartl, Thomas Reiberger and Michael Trauner from the Division of Gastroenterology ...
Jun 15, 2022
0
88
A large team of researchers from Denali Therapeutics, working with colleagues from multiple entities in the U.S. and one in Canada, has found that a LRRK2 inhibitor called DNL201 showed no ill effects to volunteers in a clinical ...
